Do you have a case that will stump your colleagues?Send in your most interesting case, and we'll post it here for your peers to see. Just provide images (jpgs, pngs, etc.) and a short write-up of the history, findings, and diagnosis along with any discussion you'd like to add. (Remeber to leave the diagnosis out until the discussion.) It's the easiest way to get published, ever.Get Started
Do you have a case that will stump your colleagues?
Send in your most interesting case, and we'll post it here for your peers to see. Just provide images (jpgs, pngs, etc.) and a short write-up of the history, findings, and diagnosis along with any discussion you'd like to add. (Remeber to leave the diagnosis out until the discussion.) It's the easiest way to get published, ever.
Get Started
FDA adds boxed warning to fezolinetant for rare serious liver injury
Published: December 17th 2024 | Updated: December 17th 2024The FDA has added a boxed warning for fezolinetant (VEOZAH; Astellas), highlighting the rare occurrence of serious liver injury in patients taking the menopause treatment.
Read More